12 Oct 2021 Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging Member news
12 Oct 2021 Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development Member news
12 Oct 2021 Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson to retire, Effective December 31, 2021 Member news
12 Oct 2021 X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership Member news
06 Oct 2021 Precirix dosed first patients in Phase I/II clinical study evaluating CAM-H2 in HER2-positive metastatic cancer Member news
06 Oct 2021 atbtherapeutics expands leadership team and Scientific Advisory Board with pharmaceutical industry experts Member news
05 Oct 2021 New Flanders360 platform puts Flanders’ life sciences & health ecosystem on the international map Member news
04 Oct 2021 Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
